Cogent NDA for Bezuclastinib Advances Under FDA RTOR
WALTHAM, Mass. & BOULDER, Colo., January 20, 2026 — Cogent Biosciences announced that the U.S. Food and Drug Administration...
.Gov for New Therapy
FDA Expands Regulatory Flexibility for Cell and Gene Therapies
White Oak, Maryland – January 2026 — The U.S. Food and Drug Administration has announced a more flexible regulatory...
Physician Shortage Strains U.S. Healthcare Systems, Report Finds
WINDHAM, New Hampshire | January 6, 2026 — Medicus Healthcare Solutions has released a comprehensive new report examining the...
IRA Triggers Early Drug Pricing Shifts Across Medicare
IRVING, Texas | January 6, 2026 — Vizient, Inc. has released a new analysis showing early and uneven shifts...
Invisible Radon Threat: Lung Group Urges Home Testing
CHICAGO | January 5, 2026 — During National Radon Action Month, the American Lung Association has issued a renewed...
FDA Recall Highlights cGxP Failures at Gold Star Facility
MINNEAPOLIS, December 26, 2025 — Gold Star Distribution, Inc. has issued a sweeping recall of all FDA-regulated products stored...
Merck–U.S. Agreement Redefines Drug Access and Pricing
RAHWAY, New Jersey, United States — December 19, 2025 — Merck & Co., known globally as MSD, has reached...
Gilead–U.S. Pact Aims to Cut Drug Costs for Americans
December 22, 2025 | Foster City, California — Gilead Sciences announced a three-year agreement with the U.S. Government designed...
BMS–U.S. Pact Expands Access to Eliquis for Americans
December 19, 2025 | Princeton, New Jersey — Bristol Myers Squibb announced a landmark agreement with the U.S. government...
CBIH Says Schedule III Shift Could Unlock Pharma-Grade Cannabis
HOUSTON, Texas — December 15, 2025 — Cannabis Bioscience International Holdings, Inc. (CBIH) issued a policy and science-focused update...